A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114

Abstract TAS‐114 is a dual deoxyuridine triphosphatase (dUTPase) and dihydropyrimidine dehydrogenase (DPD) inhibitor expected to widen the therapeutic index of capecitabine. Its maximum tolerated dose (MTD) was determined from a safety perspective in a combination study with capecitabine; however, i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Hikari Araki (Awdur), Toru Takenaka (Awdur), Koichi Takahashi (Awdur), Fumiaki Yamashita (Awdur), Kazuaki Matsuoka (Awdur), Kunihiro Yoshisue (Awdur), Ichiro Ieiri (Awdur)
Fformat: Llyfr
Cyhoeddwyd: Wiley, 2022-05-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg